AB021. Comparing the performance of two interferon-gamma release assays in autoimmune skin disease patients: a prospective study

Autoimmune skin disease patients are standardly screened for tuberculosis (TB) via interferon-gamma release assays (IGRAs) prior to starting immunosuppressive drugs or enrolling in clinical trials. Two commercial IGRAs, T-SPOT.TB (T-SPOT) and QuantiFERON-Tb Gold (QFT-G), are reported as either deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Krain, Rebecca L., Gaffney, Rebecca G., Keyes, Emily R., Feng, Rui, Werth, Victoria P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Abstract on Rheumatologic Skin Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033372/
http://dx.doi.org/10.21037/atm.2021.AB021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033372/
http://dx.doi.org/10.21037/atm.2021.AB021

Ejemplares similares